Table 5. Postoperative complications and treatments.

	dorzolamide/timolol group	acetazolamide/dexamethasone group
ocular hypotension*	V1+V2: No patient; V3-V6: 8 patients
BCVA	-0.96 (±7.07); Changes to baseline at V5: Differences between treatment groups (p = 0.0372)	-4.42 (±4.33)
Number of 5-FU injections	5.26 (±3.13; range 0 to 9 or more)	5.14 (±2.61; range 0 to 9 or more)
Number of suture lyses of filtering bleb	1.22 (±1.22; range 0 to 3–4)	1.39 (±1.37; range 0 to 3–4)
Number of needlings of the bleb	2 patients

* defined as an IOP of 0–5 mmHg